サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1247460

エレクトロレチノグラフィーの世界市場-2023-2030

Global Electroretinography Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
エレクトロレチノグラフィーの世界市場-2023-2030
出版日: 2023年03月28日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界のエレクトロレチノグラフィー市場は、2022年に4,842万米ドルに達し、2030年には最大9,352万米ドルに達することで有利な成長を遂げると予測されます。同市場は、予測期間中（2023年～2030年）に7.2%のCAGRで成長しています。

網膜電図（ERG）と呼ばれる診断手順は、光刺激に対する網膜の電気的反応を検査するものです。網膜グリアからの入力に加え、網膜ニューロンから直接発生する電流がERGの源となります。ERGは、生理的な環境で網膜の機能をモニターするための信頼性の高い非侵襲的な方法であるため、その意義は大きいです。ERGは、角膜コンタクトレンズ電極や角膜に接触させる細いファイバー電極を使用して撮影することが多いです。これらの電極により、眼球表面は網膜から発生する電気的活動を記録することができます。

市場力学

網膜疾患の有病率の上昇

網膜疾患の増加に伴い、市場の拡大が予測されます。例えば、予測期間中、網膜疾患の有病率の増加が市場拡大の原動力になると予測されています。例えば、国立眼科研究所によると、770万人が糖尿病性網膜症に罹患しています。この数字は、2030年までに1,130万人に増加すると予測されています。糖尿病患者の約45％が、ある程度糖尿病性網膜症に罹患しています。糖尿病黄斑浮腫は、糖尿病網膜症（DME）の最も典型的なタイプです。JAMA Ophthalmologyによると、745,000人のアメリカ人がDMEを患っています。

例えば、2020年のNCBIによると、40歳以上の網膜問題の有病率は5.35%から21.02%に及ぶとされます。病気の後期まで無症状である一方、網膜疾患は豊かな国々で不可逆的な失明の原因として最も頻度の高い疾患です。

治療費の高さが市場の成長を阻害します

富裕層の患者は一般的に診断検査を受けることができないため、市場は阻害されます。病院のデータ、国の労働統計、政府の保険償還を使用して、コスト予測を作成しました。

COVID-19影響度分析

パンデミック後、世界のエレクトロレチノグラフィー市場は大きく拡大すると予想されています。戸締まり、旅行制限、事業閉鎖などにより、COVID-19は様々な国の経済や産業に影響を及ぼしました。COVID-19問題は、いくつかの国の公衆衛生システムに過度の負担をかけ、ヘルスケアインフラへの長期投資の重要な必要性を強調しました。COVID-19の流行が拡大するにつれて、ヘルスケア分野の発展は鈍化すると予想されます。ライフサイエンス分野は、体外診断用医薬品の世界の需要拡大や研究開発活動により、活況を呈しています。

しかし、医療技術・画像処理市場は、手術件数の減少や機器調達の延期・遅延の結果、収益が減少しています。また、パンデミック後は、対面での診察に代わって、医療従事者間のバーチャルな診察が行われることが予想されます。デジタルヘルスは、テレヘルスがヘルスケアの提供方法を変革することで、今後数年のうちに隆盛を極めるでしょう。

目次

第1章 調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲について

第2章 定義と概要

第3章 エグゼクティブサマリー

  • タイプ別スニペット
  • タイプ別スニペット
  • アプリケーション別スニペット
  • 地域別スニペット

第4章 ダイナミックス

  • インパクトのあるファクター
    • 促進要因
      • 網膜疾患の有病率の上昇
      • 主要メーカー別新機種の発売と技術的進歩
    • 抑制要因
      • 治療費の高さが市場成長の妨げになります
    • 機会
    • 影響度分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格アナリシス
  • レギュラトリー・アナリシス

第6章 COVID-19の分析

  • COVID-19の解析について
    • COVID-19シナリオ前
    • 現在のCOVID-19シナリオ
    • ポストCOVID-19または未来シナリオ
  • COVIDの中での価格ダイナミクス-19
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • 結論

第7章 タイプ別

  • フルフィールドフラッシュERG（ffERG）
  • パターンERG（PERG）
  • 多焦点ERG（mfERG）

第8章 製品別

  • 固定式ERG機
  • ポータブルERG装置

第9章 アプリケーション別

  • 臨床応用
  • 臨床応用

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢について

  • 競合シナリオ
  • 市況分析・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Electro-Diagnostic Imaging, Inc
    • 会社概要
    • タイプ別ポートフォリオと説明
    • 財務概要
    • 主な展開
  • Roland Consult Stasche & Finger GmbH
  • Diagnosys LLC
  • Konan Medical USA, Inc.
  • CSO Italia
  • LKC Technologies, Inc
  • Welch Allyn
  • Diopsys, Inc.
  • Metrovision
  • Costruzione Strumenti Oftalmici

第13章 付録

目次
Product Code: HCIT1521

Market Overview

The global Electroretinography market reached US$ 48.42 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 93.52 million by 2030. The market is growing at a CAGR of 7.2% during the forecast period (2023-2030).

A diagnostic procedure called an electroretinogram (ERG) examines the retina's electrical reaction to a light stimulus. In addition to input from retinal glia, currents produced directly by retinal neurons are the source of the ERG. It's significant because the ERG is a reliable, non-invasive way to monitor retinal function in physiological settings. ERGs are frequently captured with the aid of a corneal contact lens electrode or a thin fiber electrode that is placed in contact with the cornea. These electrodes enable the ocular surface to record the electrical activity produced by the retina.

Market dynamics

Rising prevalence of retinal diseases

Market growth is predicted to increase with an increase in retinal disorders. For instance, over the forecast period, it is anticipated that the increased prevalence of retinal illnesses will fuel market expansion. For instance, 7.7 million people have diabetic retinopathy, according to the National Eye Institute. This figure is projected to rise to 11.3 million by the year 2030. Around 45% of patients with diabetes get diabetic retinopathy to some extent. Diabetic macular edema is the most typical type of diabetic retinopathy (DME). According to JAMA Ophthalmology, 745,000 Americans have DME.

For instance, according to the NCBI in 2020, the prevalence of retinal problems in persons over 40 ranges from 5.35% to 21.02%. While they are asymptomatic until the later stages of the disease, retinal diseases are the most frequent cause of irreversible blindness in affluent countries.

The high cost of treatment will hamper the growth of the market.

The market is hampered because wealthy patients typically cannot get diagnostic tests. Using hospital data, national labor statistics, and government insurance reimbursement, the cost projections were created.

COVID-19 Impact Analysis

Following the pandemic, the worldwide electroretinography market is anticipated to expand significantly. Due to lockdowns, travel restrictions, and business closures, the COVID-19 has had an impact on the economies and industries of many different nations. The COVID-19 problem has put an excessive strain on public health systems in several nations and emphasized the critical need for long-term investments in healthcare infrastructure. The healthcare sector's development is anticipated to slow as the COVID-19 pandemic spreads. The life sciences sector is thriving as a result of expanding global demand for in vitro diagnostic goods and R&D activity.

Yet, the medical technologies and imaging market is experiencing a decline in revenues as a result of fewer operations being performed and postponed or delayed equipment procurement. Also, after the pandemic, it is anticipated that virtual consultations between medical professionals will replace in-person consultations. Digital health will flourish in the years to come as telehealth transforms the way that healthcare is delivered.

Segment Analysis

The global Electroretinographymarket is segmented based type, Type, application and region.

The full-field flash ERG (ffERG) segment is anticipated to register the highest growth rate.

All through the projected period, the full-field flash ERG (ffERG) segment is anticipated to register the highest CAGR. The retina's mass response, known as the Full-field flash ERG (ffERG), is the aggregate of responses from different retinal sources. This is helpful for conditions like rod/cone dystrophies, cancer-associated retinopathy, and toxic retinopathies that cause widespread retinal impairment. It's important to note that the ffERG is ineffective for identifying tiny retinal lesions. The strength of the stimulus flash and the degree of adaptation both affect the components of the ffERG waveform and their underlying origins.

ffERG is an effective instrument to identify retinal pathology, track the level of retinal malfunction, and evaluate the effects of medical treatment on the retina in a clinical context. The examination of conditions including diabetic retinopathy, glaucoma, and retinitis pigmentosa, as well as the detection of toxic medication effects on the retina before serious, vision-threatening damage is done, have all been made possible by the use of ffERGs. The segment dominates the market because of the features.

Geographical Analysis

Rapid advancements in healthcare infrastructure drives the market

The market for electroretinography in North America is anticipated to have significant expansion over the ensuing years due to the region's high prevalence of retinal illnesses, expanding healthcare industry, and supportive governmental regulations.

For instance, around three million Americans, or 1% of the population, have glaucoma, according to the CDC 2021. This number is projected to rise as the American population ages; glaucoma is the third most common cause of blindness globally, contributing to up to 14% of the total number of blind people.

Optometrists and their colleagues will surely work to enhance and expand the range of services provided to glaucoma patients as the prevalence of the disease rises. We polled 667 optometrists in May 2021 to find out more about their methods for diagnosing, treating, and managing glaucoma. According to the respondents, 18% of their patients had glaucoma diagnoses, a disparity that only serves to highlight how crucial eyecare has become for the aging US population.

Competitive Landscape

The major global players Electro-Diagnostic Imaging, Inc., Roland Consult Stasche & Finger GmbH, Diagnosys LLC, Konan Medical USA, Inc., CSO Italia, LKC Technologies, Inc, Welch Allyn, Diopsys, Inc., Metrovision, Costruzione Strumenti Oftalmici.

Why Purchase the Report?

  • To visualize the global Electroretinography market segmentation based on Type, Product, Application and region,as well as understandkey commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Electroretinography market-level with all segments.
  • PDF report consists of a comprehensiveanalysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key Types of all the major players.

The global Electroretinography market report would provide approximately 61 tables,62figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising the prevalence of retinal diseases.
      • 4.1.1.2. New Type launches and technological advancements by the key players.
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost of treatment will hamper the growth of the market.
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. XX
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. PostCOVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Full-field flash ERG (ffERG) *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Pattern ERG (PERG)
  • 7.4. Multifocal ERG (mfERG)

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.1.2. Market Attractiveness Index, By Product
  • 8.2. Fixed ERG Machines*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Portable ERG Machines

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Clinical Application*
    • 9.2.1. Introduction
  • 9.3. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.4. Clinical Application

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Electro-Diagnostic Imaging, Inc *
    • 12.1.1. Company Overview
    • 12.1.2. Type Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Roland Consult Stasche & Finger GmbH
  • 12.3. Diagnosys LLC
  • 12.4. Konan Medical USA, Inc.
  • 12.5. CSO Italia
  • 12.6. LKC Technologies, Inc
  • 12.7. Welch Allyn
  • 12.8. Diopsys, Inc.
  • 12.9. Metrovision
  • 12.10. Costruzione Strumenti Oftalmici

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us